News Article

More News »

Novum’s Pina D’Angelo Presented at ICSA Symposium

Jun 12, 2017

Pittsburgh, PA: Pina D’Angelo, MSc, Novum’s Executive Director, Scientific Affairs (Biostatistics), was a Presenter at the 2017 ICSA Applied Statistics Symposium, on June 25th – 28thin Chicago, Illinois.  

On June 28th at 9:45AM, Ms. D’Angelo discussed the topic of “Statistical Analysis and Issues in Skin Adhesion Studies”.  This session provided an overview of the regulatory requirements for generic submissions of transdermal/topical patch systems with a focus on the design of and statistical analyses for adhesion studies.

For over 40 years, Novum has been considered one of the world’s leaders in the conduct of clinical trials; Early Phase Research from First in Human studies to large bioequivalence studies are conducted at Clinical Pharmacology units in Houston, Texas; Las Vegas, Nevada; and Fargo, North Dakota. A separate division, managing Late Phase Research requiring patient populations across multiple therapeutic areas, is lead by the Clinical Trials Division headquartered in Pittsburgh, Pennsylvania. 

To learn more about the Conference and/or register, click here.